Sleeping Aids Market Size, Share, Trends, Industry Analysis Report: By Product, Sleep Disorders, and Region

Description

List of Tables

The sleeping aids market size is expected to reach USD 162.84 billion by 2034, according to a new study by Polaris Market Research. The report "Sleeping Aids Market Size, Share, Trends, Industry Analysis Report: By Product (Mattresses & Pillows, Sleep Laboratories, Medications, Prescription-Based Drugs, OTC Drugs, Herbal Drugs, and Sleep Apnea Devices), Sleep Disorders, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Sleeping aids are products designed to help individuals improve their sleep quality and manage sleep-related disorders. These products include prescription medications, over-the-counter drugs, herbal supplements, and non-pharmaceutical devices such as sleep trackers and CPAP machines for sleep apnea. They are used to address conditions like insomnia, sleep apnea, restless legs syndrome, and other sleep disturbances. Sleeping aids work by promoting relaxation, improving sleep onset, or preventing wakefulness during the night, depending on the type of product.

The sleeping aids market is experiencing steady growth driven by the increasing prevalence of sleep disorders such as insomnia, sleep apnea, and restless legs syndrome. Key factors contributing to this growth include rising stress levels, an aging population, and greater awareness of the health risks associated with poor sleep. Opportunities lie in the growing demand for natural, non-habit forming alternatives and the integration of technology into sleep management, such as AI-powered sleep trackers and connected CPAP devices. Trends such as personalized sleep solutions, the use of herbal supplements, and a shift towards non-pharmaceutical treatments are shaping the market. Additionally, the expansion of e-commerce and growing interest in sleep wellness are fueling market development. As consumer awareness of the importance of quality sleep increases, the market is poised for sustained growth, with innovation in both product offerings and delivery channels.

Sleeping Aids Market Report Highlights

The OTC drugs segment dominates the market, driven by the high demand for effective treatments for insomnia and sleep apnea. However, the sleep apnea devices segment is the fastest growing due to increased awareness of sleep apnea and technological advancements in CPAP machines and other therapies.

The insomnia segment holds the largest sleeping aids market share, with a high prevalence globally and a wide range of treatment options available. The sleep apnea segment is also experiencing the fastest growth, driven by the rising diagnosis rates and the adoption of advanced sleep apnea devices.

North America dominates the sleeping aids market, with the largest market share due to the widespread prevalence of sleep disorders and advanced healthcare infrastructure. Asia Pacific is also the fastest growing region, fueled by increasing awareness of sleep health, urbanization, and rising disposable incomes.

Polaris Market Research has segmented sleeping aids market report on the basis of product, sleep disorders, and region

By Product Outlook (Revenue-USD Billion, 2020-2034)

Mattresses & Pillows
Sleep Laboratories
Medications
Prescription-based Drug
OTC Drugs
Herbal Drugs
Sleep Apnea Devices

By Sleep Disorders Outlook (Revenue-USD Billion, 2020-2034)

Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Sleep Walking
Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM2287

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Sleeping Aids Market Insights

4.1. Sleeping Aids Market - Market Snapshot
4.2. Sleeping Aids Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Sleep Disorders
  - 4.2.1.2. Rising Stress and Anxiety Levels
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Awareness
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Sleeping Aids Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Sleeping Aids Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
5.3. Mattresses & Pillows
- 5.3.1. Global Sleeping Aids Market, by Mattresses & Pillows, by Region, 2020-2034 (USD Billion)
5.4. Sleep Laboratories
- 5.4.1. Global Sleeping Aids Market, by Sleep Laboratories, by Region, 2020-2034 (USD Billion)
5.5. Medications
- 5.5.1. Global Sleeping Aids Market, by Medications, by Region, 2020-2034 (USD Billion)
5.6. Prescription-Bbased Drug
- 5.6.1. Global Sleeping Aids Market, by Prescription-Bbased Drug, by Region, 2020-2034 (USD Billion)
5.7. OTC Drugs
- 5.7.1. Global Sleeping Aids Market, by OTC Drugs, by Region, 2020-2034 (USD Billion)
5.8. Herbal Drugs
- 5.8.1. Global Sleeping Aids Market, by Herbal Drugs, by Region, 2020-2034 (USD Billion)
5.9. Sleep Apnea Devices
- 5.9.1. Global Sleeping Aids Market, by Sleep Apnea Devices, by Region, 2020-2034 (USD Billion)

6. Global Sleeping Aids Market, by Sleep Disorders

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
6.3. Insomnia
- 6.3.1. Global Sleeping Aids Market, by Insomnia, by Region, 2020-2034 (USD Billion)
6.4. Sleep Apnea
- 6.4.1. Global Sleeping Aids Market, by Sleep Apnea, by Region, 2020-2034 (USD Billion)
6.5. Restless Legs Syndrome
- 6.5.1. Global Sleeping Aids Market, by Restless Legs Syndrome, by Region, 2020-2034 (USD Billion)
6.6. Narcolepsy
- 6.6.1. Global Sleeping Aids Market, by Narcolepsy, by Region, 2020-2034 (USD Billion)
6.7. Sleep Walking
- 6.7.1. Global Sleeping Aids Market, by Sleep Walking, by Region, 2020-2034 (USD Billion)
6.8. Others
- 6.8.1. Global Sleeping Aids Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Sleeping Aids Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Sleeping Aids Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Sleeping Aids Market - North America
- 7.3.1. North America: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.3.3. Sleeping Aids Market - U.S.
  - 7.3.3.1. U.S.: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.3.4. Sleeping Aids Market - Canada
  - 7.3.4.1. Canada: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
7.4. Sleeping Aids Market - Europe
- 7.4.1. Europe: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.3. Sleeping Aids Market - UK
  - 7.4.3.1. UK: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.4. Sleeping Aids Market - France
  - 7.4.4.1. France: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.5. Sleeping Aids Market - Germany
  - 7.4.5.1. Germany: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.6. Sleeping Aids Market - Italy
  - 7.4.6.1. Italy: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.7. Sleeping Aids Market - Spain
  - 7.4.7.1. Spain: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.8. Sleeping Aids Market - Netherlands
  - 7.4.8.1. Netherlands: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.9. Sleeping Aids Market - Russia
  - 7.4.9.1. Russia: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.4.10. Sleeping Aids Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
7.5. Sleeping Aids Market - Asia Pacific
- 7.5.1. Asia Pacific: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.3. Sleeping Aids Market - China
  - 7.5.3.1. China: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.4. Sleeping Aids Market - India
  - 7.5.4.1. India: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.5. Sleeping Aids Market - Malaysia
  - 7.5.5.1. Malaysia: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.6. Sleeping Aids Market - Japan
  - 7.5.6.1. Japan: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.7. Sleeping Aids Market - Indonesia
  - 7.5.7.1. Indonesia: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.8. Sleeping Aids Market - South Korea
  - 7.5.8.1. South Korea: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.9. Sleeping Aids Market - Australia
  - 7.5.9.1. Australia: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.5.10. Sleeping Aids Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
7.6. Sleeping Aids Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.6.3. Sleeping Aids Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.6.4. Sleeping Aids Market - UAE
  - 7.6.4.1. UAE: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.6.5. Sleeping Aids Market - Israel
  - 7.6.5.1. Israel: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.6.6. Sleeping Aids Market - South Africa
  - 7.6.6.1. South Africa: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.6.7. Sleeping Aids Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
7.7. Sleeping Aids Market - Latin America
- 7.7.1. Latin America: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.7.3. Sleeping Aids Market - Mexico
  - 7.7.3.1. Mexico: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.7.4. Sleeping Aids Market - Brazil
  - 7.7.4.1. Brazil: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.7.5. Sleeping Aids Market - Argentina
  - 7.7.5.1. Argentina: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)
- 7.7.6. Sleeping Aids Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Sleeping Aids Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Sleeping Aids Market, by Sleep Disorders, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Pfizer Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. GlaxoSmithKline (GSK)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Johnson & Johnson (McNeil Consumer Healthcare)
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Sanofi S.A.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Merck & Co., Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Mylan N.V.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Teva Pharmaceutical Industries Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Bayer AG
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. ResMed Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Philips Healthcare
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development